We are live on
!
Find out more
FCM
Farallon Capital Management Portfolio holdings
AUM
$17.5B
1-Year Est. Return
50.95%
This Fund
S&P 500
This Quarter
Est. Return
+10.27%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$22.8B
AUM Growth
-$510M
(-2.2%)
Cap. Flow
-$2.26B
Cap. Flow
% of AUM
-9.9%
Top 10 Holdings %
Top 10 Hldgs %
40.08%
Holding
187
New
21
Increased
43
Reduced
39
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$207M |
| 2 |
ANSS
Ansys
ANSS
|
+$201M |
| 3 |
Woodward
WWD
|
+$192M |
| 4 |
SWN
Southwestern Energy Company
SWN
|
+$168M |
| 5 |
SQSP
Squarespace, Inc.
SQSP
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$294M |
| 2 |
Nasdaq
NDAQ
|
+$256M |
| 3 |
Salesforce
CRM
|
+$231M |
| 4 |
AstraZeneca
AZN
|
+$188M |
| 5 |
Aramark
ARMK
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.84% |
| 2 | Technology | 13.48% |
| 3 | Financials | 9.84% |
| 4 | Communication Services | 6.79% |
| 5 | Industrials | 6.15% |
Similar funds
BBA
MCM
LA
CM
ASRS
PP
VMPIC
HNB
Farallon Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Farallon Capital Management held 187 positions worth $22.8B, down 2.2% from $23.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Farallon Capital Management withdrew a net $2.26B in Q3 2024, closing 22 positions and reducing 39 holdings. Its most notable exit was AstraZeneca, an estimated $188M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Technology and Financials.
Against the trend, Farallon Capital Management opened a new position in Woodward worth $198M.
- Farallon Capital Management's largest Q3 2024 buy was Woodward: 1,154,000 shares worth $198M.
- Farallon Capital Management added most to Walt Disney in Q3 2024, an estimated $207M increase.
- Farallon Capital Management's biggest Q3 2024 reduction was UnitedHealth, cutting an estimated $294M.
- Farallon Capital Management fully exited AstraZeneca in Q3 2024, selling an estimated $188M.
- Farallon Capital Management's ten largest holdings make up 40% of its $22.8B portfolio in Q3 2024.
- Farallon Capital Management opened 21 new positions and closed 22 in Q3 2024.
- Farallon Capital Management's portfolio value fell 2.2% quarter-over-quarter to $22.8B.
Based on Farallon Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.